235 related articles for article (PubMed ID: 9268666)
1. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of proteolytic antibody light chain.
Gao QS; Sun M; Rees AR; Paul S
J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic activity of an antibody light chain.
Sun M; Gao QS; Li L; Paul S
J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
[TBL] [Abstract][Full Text] [Related]
4. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
5. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
Polymenis M; Stollar BD
J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
[TBL] [Abstract][Full Text] [Related]
6. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
7. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
Okochi N; Kato-Murai M; Kadonosono T; Ueda M
Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
[TBL] [Abstract][Full Text] [Related]
8. Recognition of DNA by VH and Fv domains of an IgG anti-poly(dC) antibody with a singly mutated VH domain.
O'Connor KC; Nguyen K; Stollar BD
J Mol Recognit; 2001; 14(1):18-28. PubMed ID: 11180559
[TBL] [Abstract][Full Text] [Related]
9. Medical applications of single-chain antibodies.
Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
[TBL] [Abstract][Full Text] [Related]
10. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
[TBL] [Abstract][Full Text] [Related]
11. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules.
Brigido MM; Polymenis M; Stollar BD
J Immunol; 1993 Jan; 150(2):469-79. PubMed ID: 8419479
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
[TBL] [Abstract][Full Text] [Related]
13. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
14. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
Riechmann L
J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
[TBL] [Abstract][Full Text] [Related]
15. Innate antibody catalysis.
Gololobov G; Sun M; Paul S
Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
[TBL] [Abstract][Full Text] [Related]
16. Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
Rinfret A; Horne C; Dorrington KJ; Klein M
J Immunol; 1985 Oct; 135(4):2574-81. PubMed ID: 3928754
[TBL] [Abstract][Full Text] [Related]
17. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
18. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
19. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
20. Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens.
Smith-Gill SJ; Hamel PA; Lovoie TB; Dorrington KJ
J Immunol; 1987 Dec; 139(12):4135-44. PubMed ID: 2447160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
